rss
Br J Ophthalmol 2004;88:1097-1098 doi:10.1136/bjo.2003.039719
  • Letter

Trans-Tenon’s retrobulbar triamcinolone infusion for small choroidal neovascularisation

  1. A A Okada,
  2. T Wakabayashi,
  3. E Kojima,
  4. Y Asano,
  5. T Hida
  1. Kyorin Eye Center, Kyorin University School of Medicine, 6–20–2 Shinkawa, Mitaka, Tokyo, Japan
  1. Correspondence to: A A Okada MD Department of Ophthalmology, Kyorin University School of Medicine, 6–20–2, Shinkawa, Mitaka, Tokyo 181–8611 Japan; aokadapo.iijnet.or.jp
  • Revised 6 January 2004

Intravitreal and sub-Tenon’s corticosteroids are being evaluated for the treatment of choroidal neovascularisation (CNV).1–3 We reported on the efficacy of triamcinolone acetonide administered as a trans-Tenon’s retrobulbar infusion (triamcinolone infusion) in reducing inflammation in uveitic eyes.4 Here we evaluated the same treatment in eyes with small subfoveal CNV.

Case reports

Triamcinolone infusion was performed in 22 eyes of 22 patients with subfoveal CNV of greatest diameter less than or equal to 1 disc diameter (DD). The diagnoses were age related macular degeneration (AMD) in 14 eyes, idiopathic CNV in four eyes, polypoidal choroidal vasculopathy (PCV) in three eyes, and punctate inner choroidopathy (PIC) in one eye. One AMD eye had undergone ablative argon laser photocoagulation for CNV previously, but no other eyes had received previous treatment. The median post-triamcinolone infusion follow up was …

[Full text of this article]

This Article

  1. Extract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.